Patent extension, page-29

  1. 208 Posts.
    lightbulb Created with Sketch. 129
    It is almost a given, they are rarely denied a patent in these circumstances.

    In regards to 510K easier to post a link

    https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/510kClearances/default.htm

    The costs etc to do with having a "generic" ReCell are many especially with a device like ReCell much more than a medicine which is a simple formula. Molds for the device which are expensive to design, make and the testing of the device working the same, it's not as bad as all th full clinical trials etc, but, it's just a lot more money, risk etc for something where the majority of the US market will be closed to them. I don't see it being worth it.
    Last edited by Tdeck1966: 21/04/19
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.81
Change
0.040(2.26%)
Mkt cap ! $128.9M
Open High Low Value Volume
$1.79 $1.83 $1.77 $166.2K 92.24K

Buyers (Bids)

No. Vol. Price($)
2 17378 $1.78
 

Sellers (Offers)

Price($) Vol. No.
$1.81 254 1
View Market Depth
Last trade - 16.10pm 15/07/2025 (20 minute delay) ?
AVH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.